Companies: 10,795·Total market cap: $144.5T
Naba Alsaha Medical Services Company

Naba Alsaha Medical Services Company

9546.SRSAUHealthcare● Active
$22.85
+$0.45(+2.01%)
Market Cap$479850000
P/E Ratio
52W High$34.65
52W Low$20.37
Overview

Naba Alsaha Medical Services Company (9546.SR) Revenue

Annual & quarterly revenue history · segment & region breakdown

9546.SR · revenue · updated Jun 15, 2026

Core revenue metrics

Naba Alsaha Medical Services Company trailing twelve-month (TTM) revenue is $0.40B, an increase of 3.88% year-over-year from $0.20B in FY2025.

TTM revenue
$0.40B
4-quarter sum · USD
YoY growth
+3.88%
vs FY2025 $0.20B
Price / sales
1.21×
mktCap ÷ TTM rev
Revenue per day
$1M
Est. TTM ÷ 365
Revenue / employee
$791K
501 employees
FY2025
$0.20B
FY2024
$0.19B
5Y CAGR
+11.4%
Fiscal year end
Dec 31
Currency
SAR · GAAP
Filing
10-K / 10-Q
Source: FMP · Naba Alsaha Medical Services Company SEC filings · GAAPUpdated: 2026-06-15

Revenue trend

20252020 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2025-12-31$0.20B+$0.01B+3.88%
2024-12-31$0.19B+$0.01B+6.54%
2023-12-31$0.18B+$0.05B+40.61%
2022-12-31$0.13B+$0.01B+10.20%
2021-12-31$0.12B+$0.00B+1.73%
2020-12-31$0.12B
9546.SR revenue by year · 9546.SR revenue history · 9546.SR annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Naba Alsaha Medical Services Company receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Naba Alsaha Medical Services Company reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in SAR.

Data sourced from Naba Alsaha Medical Services Company's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

9546.SR revenue · 4 questions

9546.SR's trailing twelve-month (TTM) revenue is $0.40B. That is an increase of 3.88% year-over-year from $0.20B in FY2025.

9546.SR revenue9546.SR annual revenuewhat is 9546.SR revenue9546.SR TTM revenue

Source: FMP · Naba Alsaha Medical Services Company SEC filings · GAAP · Naba Alsaha Medical Services Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026